In one paragraphArticle in Circulation. Heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Steven E Valdez *Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0009-0004-9707-3990 Lindsey A Taylor *Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0009-0009-5182-349X Craig H SelzmanNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0000-0001-9218-4764 Stavros G DrakosNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0000-0002-1223-327X Robin M ShawNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0000-0001-7429-6092 Joseph A PalatinusNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (S.E.V., L.A.T., C.H.S., S.G.D., R.M.S., J.A.P.).ORCID 0000-0002-6424-0105 Funding
Targeting Protein Trafficking in Arrhythmogenic CardiomyopathyK08HL155886 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PALATINUS, JOSEPH A. · 2021 to 2025
$896kConnexin 43 gap junction dynamics in the diabetic heartF30HL095320 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PALATINUS, JOSEPH A. · 2009 to 2013
$167kMyocarditis is necessary for the development of arrhythmogenic cardiomyopathyF31HL178200 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Steven Elias Valdez · 2025 to 2026
$76kNHLBI NIH HHS F30 HL095320NHLBI NIH HHS F31 HL178200NHLBI NIH HHS K08 HL155886
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
arrhythmiagenetic diseasesheart diseaseshumanmutationphenotypeprotein trafficking
Identifiers
PMID40255194
PMCPMC13293350
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390